(Q46485667)

22 December 2017

title

High plasma proteasome levels are detected in patients with metastatic malignant melanoma (English)

1 reference

22 December 2017

author name string

Stoebner PE

1

1 reference

22 December 2017

Lavabre-Bertrand T

2

1 reference

22 December 2017

Henry L

3

1 reference

22 December 2017

Guiraud I

4

1 reference

22 December 2017

Carillo S

5

1 reference

22 December 2017

Dandurand M

6

1 reference

22 December 2017

Joujoux JM

7

1 reference

22 December 2017

Bureau JP

8

1 reference

22 December 2017

Meunier L

9

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

British Journal of Dermatology

published in

1 reference

22 December 2017

volume

152

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

948-953

1 reference

22 December 2017

The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Degradation of oxidized proteins by the 20S proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

The proteasome: structure, function, and role in the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Proteasome and class I antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Prosomes (proteasomes) changes during differentiation are related to the type of inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Skin proteasomes (high-molecular-weight protease): purification, enzymologic properties, gross structure, and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Impairment of proteasome structure and function in aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Impairment of proteasome function upon UVA- and UVB-irradiation of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

A new American Joint Committee on Cancer staging system for cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Role of the ubiquitin-proteasome pathway in the diagnosis of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

The proteasome, a new target for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Clinical update: proteasome inhibitors in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Reduced cyclin D1 ubiquitination in UVB-induced murine squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

An antigenic peptide produced by peptide splicing in the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Serological markers for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

Immunopathogenic mechanisms in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06487.X

10.1111/J.1365-2133.2005.06487.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017